Literature DB >> 8676513

Infection of class II-deficient mice by the DA strain of Theiler's virus.

L Fiette1, M Brahic, C Pena-Rossi.   

Abstract

The DA strain of Theiler's virus causes, in susceptible strains of mice, a persistent infection of the white matter of the spinal cord accompanied by chronic inflammation and primary demyelination. In resistant strains, including all H-2b strains, mice clear the infection after 1 to 2 weeks. We inoculated RHAbetao/o mice, an H-2b strain which does not express class II molecules. We found that they are susceptible to persistent infection and that they develop foci of chronic inflammation with demyelination. However, these foci are smaller and contain fewer demyelinated axons than those observed in susceptible SJL/J or beta2m-/- mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676513      PMCID: PMC190423     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Analysis of proteolipid protein and P0 transcripts in mice infected with Theiler's virus.

Authors:  S Ozden; C Aubert; J F Bureau; D Gonzalez-Dunia; M Brahic
Journal:  Microb Pathog       Date:  1993-02       Impact factor: 3.738

2.  FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.

Authors:  A Azoulay; M Brahic; J F Bureau
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.

Authors:  S J Gerety; M K Rundell; M C Dal Canto; S D Miller
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

4.  Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice.

Authors:  H L Lipton; R Melvold
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

5.  Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice.

Authors:  M K Njenga; K D Pavelko; J Baisch; X Lin; C David; J Leibowitz; M Rodriguez
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Theiler's virus infection of beta 2-microglobulin-deficient mice.

Authors:  L Fiette; C Aubert; M Brahic; C P Rossi
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination.

Authors:  L C Pullen; S D Miller; M C Dal Canto; B S Kim
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

8.  Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction.

Authors:  W J Karpus; J G Pope; J D Peterson; M C Dal Canto; S D Miller
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

9.  Theiler's virus persists in glial cells during demyelinating disease.

Authors:  M Brahic; W G Stroop; J R Baringer
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

10.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.

Authors:  S J Gerety; W J Karpus; A R Cubbon; R G Goswami; M K Rundell; J D Peterson; S D Miller
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

View more
  10 in total

1.  Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.

Authors:  A J Johnson; M K Njenga; M J Hansen; S T Kuhns; L Chen; M Rodriguez; L R Pease
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.

Authors:  M K Njenga; K Asakura; S F Hunter; P Wettstein; L R Pease; M Rodriguez
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination.

Authors:  Kristen M Drescher; Laurie J Zoecklein; Moses Rodriguez
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

4.  Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies.

Authors:  Z C Neal; G A Splitter
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficits.

Authors:  Paul D Murray; Dorian B McGavern; Larry R Pease; Moses Rodriguez
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

Review 6.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

7.  Human HLA-DR transgenes protect mice from fatal virus-induced encephalomyelitis and chronic demyelination.

Authors:  Moses Rodriguez; Laurie Zoecklein; Jason G Kerkvliet; Kevin D Pavelko; Louisa Papke; Charles L Howe; Larry R Pease; Chella David
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

8.  Human class I major histocompatibility complex alleles determine central nervous system injury versus repair.

Authors:  Bharath Wootla; Aleksandar Denic; Jens O Watzlawik; Arthur E Warrington; Laurie J Zoecklein; Louisa M Papke-Norton; Chella David; Moses Rodriguez
Journal:  J Neuroinflammation       Date:  2016-11-17       Impact factor: 8.322

9.  MHC class II-alpha chain knockout mice support increased viral replication that is independent of their lack of MHC class II cell surface expression and associated immune function deficiencies.

Authors:  Mohammed Alsharifi; Aulikki Koskinen; Danushka K Wijesundara; Jayaram Bettadapura; Arno Müllbacher
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  Transcriptome analysis following neurotropic virus infection reveals faulty innate immunity and delayed antigen presentation in mice susceptible to virus-induced demyelination.

Authors:  Malgorzata Ciurkiewicz; Stefan Floess; Michael Beckstette; Maren Kummerfeld; Wolfgang Baumgärtner; Jochen Huehn; Andreas Beineke
Journal:  Brain Pathol       Date:  2021-07-06       Impact factor: 6.508

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.